Free Widgets | Feedback 
Live Share Markets - Appuonline.com


Updated:21 Jul 2017 03:31:00 PM(IST)

Investor Tool

My Stockwatch 

RELIANCE 1585.00 [ +3.67% ]TCS 2491.20 [ +1.90% ]

Sensex32028.89
124.49 0.39%

Nifty9915.25
41.95 0.42%

Midcap15185.53
6.26 0.04%

Smallcap15992.63
-7.25 -0.05%


Bse Corporate Announcements Back
Sun Pharmaceuticals received tentative approval for generic Lunesta
Sun Pharmaceuticals received tentative approval for generic Lunesta Glenmark Pharmaceuticals, Orchid chemicals & Pharmaceuticals, Mylan Pharma have already received tentative approval from US FDA. Sun Pharmaceuticals received tentative approval for Abbreviated New Drug Application (ANDA) from US Food and Drug Administration (USFDA) for Eszopiclone oral tablets in multiple strengths of 1 mg, 2 mg, and 3 mg. It was originally developed and marketed by the Sepracor (renamed to Sunovion Pharma) under the brand name drug Lunesta. The drug is indicative for the treatment of insomnia. It had annual sales of USD 787 million for twelve months ended September 2010. Further, the patent is set to expire in 2014. Glenmark Pharmaceuticals, Orchid Chemicals & Pharmaceuticals, Mylan Pharma have already received tentative approval from US FDA.

Market on Mobile
























Site Map  •  Mobile  •  Companies  •  Learning Centre  •  Insurance •  About  •  Contact us  •  Disclaimer
© appuonline.com